Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 350 of 672 entries
View as:

Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults

Phase: N/A Priority: Normal
NCT ID: NCT01667731 Org: User:
Start: 07/31/12 End: 02/28/14 Due: 02/28/15

Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on Metformin

Phase: N/A Priority: Normal
NCT ID: NCT00814372 Org: User:
Start: 12/31/08 End: 02/28/10 Due: 02/28/11

Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT02889796 Org: User:
Start: 08/30/16 End: 06/20/19 Due: 06/20/20

Stress Echocardiography Study With Regadenoson

Phase: N/A Priority: Normal
NCT ID: NCT00907764 Org: User:
Start: 04/30/09 End: 04/30/10 Due: 04/30/11

Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alobresib (Formerly GS-5829) in Adults With Advanced Solid Tumors and Lymphomas and in Combination With Exemestane or Fulvestrant in Adults With Estrogen Receptor Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02392611 Org: User:
Start: 03/16/15 End: 10/11/17 Due: 10/11/18

A Multiple Ascending Dose Study of GS 5885 in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

Phase: N/A Priority: Normal
NCT ID: NCT01193478 Org: User:
Start: 08/31/10 End: 12/31/11 Due: 12/31/12

A Randomized, Double-Blind, Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Phase: N/A Priority: Normal
NCT ID: NCT01539512 Org: User:
Start: 04/30/12 End: 04/30/14 Due: 04/30/15

A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2, 3 and 4 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults

Phase: N/A Priority: Normal
NCT ID: NCT01783678 Org: User:
Start: 01/31/13 End: 07/31/14 Due: 07/31/15

GS-6615 in Adults With Chronic Stable Angina and Coronary Artery Disease

Phase: N/A Priority: Normal
NCT ID: NCT02377336 Org: User:
Start: 05/31/15 End: 08/31/16 Due: 08/31/17

Study to Evaluate the Pharmacokinetics of Selonsertib in Participants With Normal and Impaired Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT02509624 Org: User:
Start: 08/18/15 End: 12/15/15 Due: 12/15/16

Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents With Chronic Hepatitis B

Phase: N/A Priority: Normal
NCT ID: NCT00095121 Org: User:
Start: 06/30/04 End: 04/30/10 Due: 04/30/11

A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone

Phase: N/A Priority: Normal
NCT ID: NCT01555164 Org: User:
Start: 06/30/12 End: 10/31/13 Due: 10/31/14

Study of Oral Weekly GS-1720 and GS-4182 Compared With Biktarvy in People With HIV-1 Who Have Not Been Treated

Phase: N/A Priority: Normal
NCT ID: NCT06613685 Org: User:
Start: 10/21/24 End: 08/31/30 Due: 08/31/31

Study of GS-0151 in Participants With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT06902519 Org: User:
Start: 05/14/25 End: 01/31/27 Due: 01/31/28

Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Cholangitis (PSC)

Phase: N/A Priority: Normal
NCT ID: NCT01672853 Org: User:
Start: 03/04/13 End: 08/24/16 Due: 08/24/17

Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study

Phase: N/A Priority: Normal
NCT ID: NCT03118843 Org: User:
Start: 04/25/17 End: 03/19/18 Due: 03/19/19

Phase I/II Study of hLL1 in Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00421525 Org: User:
Start: 01/31/07 End: 06/30/09 Due: 06/30/10

Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract

Phase: N/A Priority: Normal
NCT ID: NCT02254408 Org: User:
Start: 01/23/15 End: 07/14/17 Due: 07/14/18

Study to Investigate Idelalisib in Combination With Chemotherapeutic Agents, Immunomodulatory Agents and Anti-CD20 Monoclonal Antibody (mAb) in Participants With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01088048 Org: User:
Start: 03/25/10 End: 04/28/15 Due: 04/28/16

A Phase II Study of IMMU 130 in Patients With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01915472 Org: User:
Start: 09/30/13 End: 08/31/15 Due: 08/31/16

Safety and Efficacy of GS-4774 for the Treatment of Chronic Hepatitis B

Phase: N/A Priority: Normal
NCT ID: NCT01943799 Org: User:
Start: 09/13/13 End: 03/03/15 Due: 03/03/16

Immune Response to Influenza Vaccine in Adults With B-cell Malignancies Treated With Idelalisib

Phase: N/A Priority: Normal
NCT ID: NCT03701438 Org: User:
Start: 10/23/18 End: 10/09/19 Due: 10/09/20

Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06082960 Org: User:
Start: 10/09/23 End: 11/30/26 Due: 11/30/27

Study to Evaluate the Pharmacokinetics of Firsocostat or Fenofibrate in Adults With Normal and Impaired Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT02891408 Org: User:
Start: 09/23/16 End: 05/13/19 Due: 05/13/20

Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting

Phase: N/A Priority: Normal
NCT ID: NCT04501952 Org: User:
Start: 09/18/20 End: 05/06/21 Due: 05/06/22